Literature DB >> 23907695

Spontaneous regression of proximal LAD subocclusive stenosis after left internal mammary artery bypass grafting.

S Dodic1, D Kovacevic, M Bjelobrk, M Petrovic, T Miljkovic, M Cankovic, B Vujin, N Cemerlic-Adjic, B Dodic.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23907695     DOI: 10.1007/s00059-013-3907-y

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


× No keyword cloud information.
  15 in total

1.  A direct comparison of intravascular ultrasound and quantitative coronary arteriography: implications for measures of atherosclerosis as clinical surrogates.

Authors:  B Greg Brown
Journal:  Circulation       Date:  2007-04-10       Impact factor: 29.690

2.  Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study.

Authors:  X Q Zhao; C Yuan; T S Hatsukami; E H Frechette; X J Kang; K R Maravilla; B G Brown
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-10       Impact factor: 8.311

3.  Regression of peripheral atherosclerosis during therapy with high doses of nicotinic acid.

Authors:  C R Ost; S Sténson
Journal:  Scand J Clin Lab Invest Suppl       Date:  1967

4.  Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death.

Authors:  A H Kragel; S G Reddy; J T Wittes; W C Roberts
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

5.  Prognostic significance of progression of coronary atherosclerosis.

Authors:  D Waters; T E Craven; J Lespérance
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

6.  Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

Authors:  Steven E Nissen; Stephen J Nicholls; Ilke Sipahi; Peter Libby; Joel S Raichlen; Christie M Ballantyne; Jean Davignon; Raimund Erbel; Jean Charles Fruchart; Jean-Claude Tardif; Paul Schoenhagen; Tim Crowe; Valerie Cain; Kathy Wolski; Marlene Goormastic; E Murat Tuzcu
Journal:  JAMA       Date:  2006-03-13       Impact factor: 56.272

7.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Paul Schoenhagen; B Greg Brown; Peter Ganz; Robert A Vogel; Tim Crowe; Gail Howard; Christopher J Cooper; Bruce Brodie; Cindy L Grines; Anthony N DeMaria
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

8.  A maximum confidence approach for measuring progression and regression of coronary artery disease in clinical trials.

Authors:  B G Brown; L A Hillger; C Lewis; X Q Zhao; D Sacco; B Bisson; L Fisher
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690

9.  Regression of coronary atherosclerosis through healthy lifestyle in coronary artery disease patients--Mount Abu Open Heart Trial.

Authors:  Satish K Gupta; Ramesh C Sawhney; Lajpat Rai; V D Chavan; Sameer Dani; Ramesh C Arora; W Selvamurthy; H K Chopra; Navin C Nanda
Journal:  Indian Heart J       Date:  2011 Sep-Oct

Review 10.  Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.

Authors:  B G Brown; X Q Zhao; D E Sacco; J J Albers
Journal:  Circulation       Date:  1993-06       Impact factor: 29.690

View more
  3 in total

1.  Complete disappearance of coronary pathology.

Authors:  Slobodan Dodic; T Miljkovic; M Bjelobrk; M Kovacevic; S Colakovic; F Adjic; B Dodic
Journal:  Herz       Date:  2015-11       Impact factor: 1.443

2.  Disappearance of subocclusive ostial stenosis of the left anterior descending artery.

Authors:  Tomislav Miljak
Journal:  Herz       Date:  2015-07-28       Impact factor: 1.443

3.  What's new in the renin-angiotensin system?

Authors:  A I Smith; A J Turner
Journal:  Cell Mol Life Sci       Date:  2004-11       Impact factor: 9.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.